[
    [
        {
            "time": "",
            "original_text": "药企高管详解一季度业绩分化，市场走势分析师存分歧",
            "features": {
                "keywords": [
                    "药企",
                    "高管",
                    "一季度",
                    "业绩分化",
                    "市场走势",
                    "分析师分歧"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药企高管详解一季度业绩分化，市场走势分析师存分歧",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "药企高管详解一季度业绩分化 市场走势分析师存分歧 盈利能力下降",
            "features": {
                "keywords": [
                    "药企",
                    "高管",
                    "一季度",
                    "业绩分化",
                    "市场走势",
                    "分析师分歧",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药企高管详解一季度业绩分化 市场走势分析师存分歧 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "药企高管详解Q1业绩分化 市场走势分析师存分歧 盈利能力下降",
            "features": {
                "keywords": [
                    "药企",
                    "高管",
                    "Q1",
                    "业绩分化",
                    "市场走势",
                    "分析师分歧",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药企高管详解Q1业绩分化 市场走势分析师存分歧 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]